Travere Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.5M | 393k | 8.99 |
| 2023-09-30 | $6.6M | 734k | 8.94 |
| 2023-06-30 | $1.1M | 69k | 15.36 |
| 2023-03-31 | $22M | 960k | 22.49 |
| 2022-12-31 | $20M | 964k | 21.03 |
| 2022-06-30 | $32M | 1.3M | 24.23 |
| 2022-03-31 | $37M | 1.5M | 25.77 |
| 2021-12-31 | $28M | 899k | 31.04 |
| 2021-09-30 | $21M | 870k | 24.25 |
| 2021-06-30 | $1.6M | 110k | 14.59 |
| 2021-03-31 | $2.4M | 95k | 24.95 |
| 2020-12-31 | $28M | 1.0M | 27.26 |